SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 688179 for the last quarter is 137.37 M CNY, and it's 0.69% lower compared to the previous quarter. The net income of Q3 24 is 25.30 M CNY.